Astrana Health, Inc. (ASTH)
- Previous Close
40.02 - Open
40.02 - Bid 41.09 x 100
- Ask 41.27 x 100
- Day's Range
40.01 - 41.37 - 52 Week Range
28.87 - 45.71 - Volume
183,359 - Avg. Volume
153,322 - Market Cap (intraday)
1.871B - Beta (5Y Monthly) 1.12
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 5, 2024 - Aug 9, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
49.77
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
www.astranahealth.com1,800
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ASTH
Performance Overview: ASTH
Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ASTH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ASTH
Valuation Measures
Market Cap
1.82B
Enterprise Value
1.91B
Trailing P/E
30.32
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.30
Price/Book (mrq)
2.78
Enterprise Value/Revenue
1.32
Enterprise Value/EBITDA
14.35
Financial Highlights
Profitability and Income Statement
Profit Margin
4.29%
Return on Assets (ttm)
5.19%
Return on Equity (ttm)
12.23%
Revenue (ttm)
1.45B
Net Income Avi to Common (ttm)
62.42M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
337.29M
Total Debt/Equity (mrq)
95.83%
Levered Free Cash Flow (ttm)
209.6M
Research Analysis: ASTH
Company Insights: ASTH
ASTH does not have Company Insights